Cancer survival in Africa, Asia, and Central America: a population-based study

被引：419

作者：

Sankaranarayanan, Rengaswamy ^{[1
]}

Swaminathan, Rajaraman ^{[2
,3
]}

Brenner, Hermann ^{[4
]}

Chen, Kexin ^{[5
]}

Chia, Kee Seng ^{[6
]}

Chen, Jian Guo ^{[7
]}

Law, Stephen C. K. ^{[8
]}

Ahn, Yoon-Ok ^{[9
]}

Xiang, Yong Bing ^{[10
]}

Yeole, Balakrishna B. ^{[11
]}

Shin, Hai Rim ^{[12
]}

Shanta, Viswanathan ^{[2
,3
]}

Woo, Ze Hong ^{[13
]}

Martin, Nimit ^{[14
]}

Sumitsawan, Yupa ^{[15
]}

Sriplung, Hutcha ^{[16
]}

Barboza, Adolfo Ortiz ^{[17
]}

Eser, Sultan ^{[18
]}

Nene, Bhagwan M. ^{[19
]}

Suwanrungruang, Krittika ^{[20
]}

Jayalekshmi, Padmavathiamma ^{[21
]}

Dikshit, Rajesh ^{[22
]}

Wabinga, Henry ^{[23
]}

Esteban, Divina B. ^{[24
]}

Laudico, Adriano ^{[25
]}

Bhurgri, Yasmin ^{[26
]}

Bah, Ebrima ^{[27
]}

Al-Hamdan, Nasser ^{[28
]}

机构：

[1] Int Agcy Res Canc, Early Detect & Prevent Sect, Screening Grp, F-69372 Lyon, France

[2] Canc Inst WIA, Div Epidemiol, Chennai, Tamil Nadu, India

[3] Canc Inst WIA, Canc Registry, Chennai, Tamil Nadu, India

[4] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany

[5] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China

[6] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore

[7] Qidong Liver Canc Inst, Qidong Canc Registry, Jiangsu, Peoples R China

[8] Hosp Author, Hong Kong Canc Registry, Hong Kong, Hong Kong, Peoples R China

[9] Seoul Natl Univ, Coll Med, Seoul Canc Registry, Seoul, South Korea

[10] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China

[11] Indian Canc Soc, Bombay Canc Registry, Mumbai, Maharashtra, India

[12] Natl Canc Ctr, Res Inst, Busan Canc Registry, Kyonggi Do, South Korea

[13] Inha Univ, Incheon Canc Registry, Inchon, South Korea

[14] Lampang Canc Ctr, Lampang Canc Registry, Lampang, Thailand

[15] Chiang Mai Univ, Dept Otolaryngol, Chiang Mai 50000, Thailand

[16] Prince Songkla Univ, Songkhla Canc Registry, Hat Yai, Thailand

[17] Costa Rica Natl Tumor Registry, San Jose, Costa Rica

[18] Izmir Prov Hlth Directorate, Izmir Canc Registry, Alsancak, Turkey

[19] Nargis Dutt Mem Canc Hosp, Barshi Canc Registry, Barshi, India

[20] Khon Kaen Univ, Srinagarind Hosp, Canc Unit, Khon Kaen, Thailand

[21] Nat Background Radiat Registry, Karunagappally, Kerala, India

[22] Tata Mem Hosp, Mumbai 400012, Maharashtra, India

[23] Makerere Univ, Fac Med, Kampala Canc Registry, Kampala, Uganda

[24] Rizal Med Ctr, Rizal Canc Registry, Pasig, Philippines

[25] Manila Canc Registry, Philippine Canc Soc, Manila, Philippines

[26] Liaquat Natl Med Coll, Karachi Canc Registry, Karachi, Pakistan

[27] Natl Canc Registry Gambia, Banjul, Gambia

[28] King Fahad Med City, Fac Med, Riyadh, Saudi Arabia

来源：

LANCET ONCOLOGY | 2010年 / 11卷 / 02期

基金：

比尔及梅琳达.盖茨基金会;

关键词：

ALTERNATIVE APPROACH; PATIENT SURVIVAL; REGISTRIES;

D O I：

10.1016/S1470-2045(09)70335-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background Population-based cancer survival data, a key indicator for monitoring progress against cancer, are not widely available from countries in Africa, Asia, and Central America. The aim of this study is to describe and discuss cancer survival in these regions. Methods Survival analysis was done for 341658 patients diagnosed with various cancers from 1990 to 2001 and followed up to 2003, from 25 population-based cancer registries in 12 countries in sub-Saharan Africa (The Gambia, Uganda), Central America (Costa Rica), and Asia (China, India, Pakistan, Philippines, Saudi Arabia, Singapore, South Korea, Thailand, Turkey). 5-year age-standardised relative survival (ASRS) and observed survival by clinical extent of disease were determined. Findings For cancers in which prognosis depends on stage at diagnosis, survival was highest in China, South Korea, Singapore, and Turkey and lowest in Uganda and The Gambia. 5-year ASRS ranged from 76-82% for breast cancer, 63-79% for cervical cancer, 71-78% for bladder cancer, and 44-60% for large-bowel cancers in China, Singapore, South Korea, and Turkey. Survival did not exceed 22% for any cancer site in The Gambia; in Uganda, survival did not exceed 13% for any cancer site except breast (46%). Variations in survival correlated with early detection initiatives and level of development of health services. Interpretation The wide variation in cancer survival between regions emphasises the need for urgent investments in improving awareness, population-based cancer registration, early detection programmes, health-services infrastructure, and human resources.

引用

页码：165 / 173

页数：9

共 27 条

[1]

[Anonymous], INT STAT CLASS DIS R

[2]

[Anonymous], 1995, IARC SCI PUBLICATION

[3]

[Anonymous], 2006, SEER CANC STAT REV 1

[4] An alternative approach to age adjustment of cancer survival rates [J].

Brenner, H ;

Arndt, V ;

Gefeller, O ;

Hakulinen, T .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (15) :2317-2322

[5] A computer program for period analysis of cancer patient survival [J].

Brenner, H ;

Gefeller, O ;

Hakulinen, T .

EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) :690-695

[6]

Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO

[7]

2-#

[8] Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries [J].

Brenner, Hermann ;

Hakulinen, Timo .

INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) :432-437

[9] Cancer survival in five continents: a worldwide population-based study (CONCORD) [J].

Coleman, Michel P. ;

Quaresma, Manuela ;

Berrino, Franco ;

Lutz, Jean-Michel ;

De Angelis, Roberto ;

Capocaccia, Riccardo ;

Baili, Paolo ;

Rachet, Bernard ;

Gatta, Gemma ;

Hakulinen, Timo ;

Micheli, Andrea ;

Sant, Milena ;

Weir, Hannah K. ;

Elwood, J. Mark ;

Tsukuma, Hideaki ;

Koifman, Sergio ;

Azevedo e Silva, Gulnar ;

Francisci, Silvia ;

Santaquilani, Mariano ;

Verdecchia, Arduino ;

Storm, Hans H. ;

Young, John L. .

LANCET ONCOLOGY, 2008, 9 (08) :730-756

[10]

Curado M.P., 2007, IARC Scientific Publication, V160

← 1 2 3 →